Follow
Data integrity is the property of a data set that ensures that the information it contains is correct and has not been tampered with. Data integrity is important for a variety of reasons, including ensuring the accuracy of patient information, protecting intellectual property, and protecting against fraud.
The pharmaceutical industry is particularly sensitive to data integrity issues, as inaccurate or fraudulent data can lead to regulatory fines or even product recalls.
In this blog post, we will explore some of the factors that contribute to data integrity and how important it is to pharmaceutical regulatory agencies.
Why is data integrity important to regulatory agencies?
As the FDA and other regulatory agencies face increasing pressure to approve drugs quickly and with minimal side effects, data integrity is critical. If the data is incorrect or fraudulent, it can cause serious problems for drug approval and even safety. Inaccurate or fraudulent information can also affect patient care and lead to litigation.
A recent study found that drug approvals are more likely to be denied if a company has had data integrity issues in the past. This suggests that regulators are looking for companies that have a good track record of keeping data accurate and up to date.
If your company relies on data from third-party suppliers, it’s important to ensure the data is accurate and up-to-date. If you become aware that your suppliers have data integrity issues, you should report them to regulators as soon as possible.
